Kindred Biosciences reported 5.87M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Adma Biologics ADMA:US $ 13.87M 631.53K
Bayer BAYN:GR 3.77B 19M
Biocryst Pharmaceuticals BCRX:US $ 34.99M 8.67M
Dynavax Technologies DVAX:US $ 26.93M 5.85M
Eli Lilly And LLY:US $ 1.58B 107.8M
Idexx Laboratories IDXX:US $ 206.53M 14.17M
JAZZ PHA JAZZ:US 363.68M 65.35M
Kindred Biosciences KIN:US 5.87M 1.18M
Merk MRK:US $ 2.27B 9M
Minerva Neurosciences NERV:US $ 3M 437.6K
Novavax NVAX:US $ 77.79M 4.63M
Phibro Animal Health PAHC:US $ 50.07M 604K
Zoetis ZTS:US $ 504M 9M